Commit Biologics
Aarhus, DK · Founded 2021 · 32 employees on LinkedIn · 3 known investors
Commit Biologics develops a complement-targeted drug discovery platform and antibody-based therapeutics for oncology, autoimmune diseases, and infectious disease indications. The company combines structural biology and complement research to advance novel therapeutic programs.
Founders & leadership
Commit Biologics was founded in 2021 by Dennis, Nick, Mikael, and Heidi.
D
DennisCOO & Co-founder
N
NickHead of Discovery & Co-founder
M
MikaelHead of Platform Technology & Co-founder
H
HeidiHead of Drug Screening & Co-founder
T
ThomasCEO
Investors · 3
Funding
SEC filings, press & company announcements- Undisclosed amountextension to Seed FinancingJan 2025Source ↗
- Undisclosed amountseed financingMay 2024 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Atira Raises $15 Mn to Bring AI Automation to Industrial Salesstartuprise.co.uk · Sep 2026Frequently asked questions
- What does Commit Biologics do?
- Commit Biologics develops a complement-targeted drug discovery platform and antibody-based therapeutics for oncology, autoimmune diseases, and infectious disease indications. The company combines structural biology and complement research to advance novel therapeutic programs.
- Who founded Commit Biologics?
- Commit Biologics was founded by Dennis, Nick, Mikael, Heidi in 2021.
- Who are Commit Biologics's investors?
- Commit Biologics's investors include Korys, Bioqube Ventures, Novo Holdings.
- Where is Commit Biologics headquartered?
- Commit Biologics is headquartered in Aarhus, DK.